Scarica l'app Stockscreener
35.71
0.93%
0.33
Dopo l'orario di chiusura:
35.71
Indivior Pharmaceuticals Inc Borsa (INDV) Ultime notizie
Halper Sadeh LLC is Investigating Whether ITGR, FHB, INDV, LNTH are Obtaining Fair Deals for their Shareholders - GlobeNewswire Inc.
Three parties report a passive holding above 5% in Indivior (INDV). - Stock Titan
Indivior stock: company declares conditional USD 8.13 special dividend - AD HOC NEWS
Indivior Pharmaceuticals, Inc. (INDV) Stock Price, News, Quote & History - Yahoo! Finance Canada
Indivior Pharmaceuticals, Inc. (INDV) Stock Forecasts - Yahoo Finance
Indivior stock gains 2.96 percent on USD 8.13 dividend plan - AD HOC NEWS
Indivior stock last trades at USD 36.88 on September 28, 2026 - AD HOC NEWS
Legend's five-year data suggests Carvykti could be a cure; Addex and Indivior split up - Endpoints News
Indivior stock at USD 35.82 on September 25, 2026 - AD HOC NEWS
Addex rises as it regains GABAB portfolio from Indivior - The Pharma Letter
Indivior stock carries a USD 8.13 special dividend - AD HOC NEWS
A research partnership ends, returning a substance-use drug candidate to Addex (ADXN). - Stock Titan
Indivior stock heads into the open after a 0.14 percent fall - AD HOC NEWS
Addex Regains Rights to GABAB Positive Allosteric Modulator Portfolio from Indivior - marketscreener.com
Indivior stock heads into the open after a 0.77 percent drop - AD HOC NEWS
Indivior Pharmaceuticals stock reports USD 8.13 special dividend - AD HOC NEWS
Layoff Tracker: Novo workforce down 13,000 - BioSpace
Supernus, Indivior get early termination of US waiting period - MLex
Indivior stock holds steady as investors watch fundamentals and momentum - AD HOC NEWS
Indivior Pharmaceuticals Inc (INDV) Stock Up 3.9% but GF Value S - GuruFocus
Indivior stock gains on $8.13 special dividend - AD HOC NEWS
Indivior (NASDAQ: INDV) Announces Conditional $8.13 Special Dividend Pending Merger Completion - Kalkine Media
Indivior declares $8.13 special dividend contingent on merger By Investing.com - Investing.com Nigeria
Form 8K Indivior PLC For: 17 September By Investing.com - Investing.com Australia
Indivior Declares $8.13 Per Share Special Dividend Tied to Supernus Merger Closing - Minichart
Indivior Sets Special Cash Dividend at $8.13 a Share Contingent on Completion of Supernus Merger - Yahoo Finance
Indivior Declares $8.13 Special Cash Dividend Tied to Supernus Merger - TradingView
An $8.13 cash payout at Indivior (INDV) hinges on a merger closing - Stock Titan
Indivior Pharmaceuticals, Inc. Declares Special Cash Dividend - Indivior
Indivior declares $8.13 special dividend contingent on merger - Investing.com
Indivior stock heads into the open after a 0.7% Nasdaq drop - AD HOC NEWS
Understanding Opioid Use Disorder: A Treatable Brain Disease - Indivior
Indivior Accelerates Termination of Suboxone Supply Agreement with Reckitt Benckiser - Kalkine Media
Indivior Pharmaceuticals to end supply agreement with Reckitt Benckiser in January - Investing.com Canada
Form 8K Indivior PLC For: 15 September By Investing.com - Investing.com Nigeria
Indivior PharmaceuticalsCopacker Supply Ag - Moomoo
Indivior Pharmaceuticals, Inc. SEC Filing (Sep 14, 2026) - Stock Titan
$1 billion dividend hangs on Supernus (NASDAQ: SUPN) merger vote - Stock Titan
Indivior stock gains as Supernus merger and special dividend plan come into focus - AD HOC NEWS
Indivior (INDV) plans special dividend if Supernus merger closes, with two payout structures - Stock Titan
SUPN: Strong CNS portfolio growth, innovative pipeline, and Indivior merger set to drive future expansion - TradingView
Indivior stock gains on raised 2026 guidance and Supernus deal - ad-hoc-news.de
Indivior stock rises on strong Q2 2026 earnings and higher full-year guidance - AD HOC NEWS
Indivior stock gains on raised 2026 outlook and strong Sublocade growth - AD HOC NEWS
Indivior Pharmaceuticals Inc. (INDV) Down 5.3% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Price to earnings forward of Indivior Pharmaceuticals, Inc. – NASDAQ:INDV - TradingView
Indivior Pharmaceuticals Inc. (INDV) Loses 12.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
INDV Stock Alert: Halper Sadeh LLC is Investigating Whether Indiv - The National Law Review
INDV Stock Alert: Halper Sadeh LLC is Investigating Whether Indivior Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders - FinancialContent
Indivior stock trades below fair value as latest earnings beat expectations - AD HOC NEWS
Why Indivior Pharmaceuticals (INDV) Is Back In The Spotlight - sahmcapital.com
Indivior Pharmaceuticals CAO Woodrow D. Anderson Acquires 1,500 Shares at $35.69 Each - Kalkine Media
Indivior (INDV) accounting chief adds 1,500 shares in market or private buy - Stock Titan
3 Reasons Why Growth Investors Shouldn't Overlook Indivior Pharmaceuticals Inc. (INDV) - Yahoo Finance
Indivior (INDV) Results Review: Profit Per Share Surpasses Its Benchmark in the Current Update - careplusvn.com
Indivior (INDV) Range: Slides 2.41% to $36.87 at the Close; Technical Setup: Support at $35.03 and Resistance at $38.71 Frame the Range in the Latest SessionGEX Level - careplusvn.com
Indivior Pharmaceuticals (INDV) Could Be 30% Undervalued On Its Cost Reset Plan - Yahoo Finance
Indivior's Supernus Merger Could Broaden Its Growth Engine in 2026 - Barchart.com
1.15%
5.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):